MR. MATTHEW AARON BRAZER RPH
Prescription History 1073864310
Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Eugene, OR
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. MATTHEW AARON BRAZER RPH, an active Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist specialist practicing in Eugene, OR. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 128 documented patient claims. Among these therapy options, the most frequently utilized medication is Shingrix, which accounts for 40 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OR PrescribersVs. OR Avg |
|---|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 40 | $211.22 | ≈ Typical |
About Shingrix: This vaccine is used by adults to prevent zoster (shingles). Show more ▾ Zoster is caused by the same virus that causes chickenpox. After you have been infected with chickenpox (usually in childhood), the virus can live in your body's nerve roots in an inactive form. For reasons that are not fully understood, the virus may become active again. This causes shingles with symptoms of rash, blisters, and pain. This vaccine works by boosting the body's natural defense (immunity) against the zoster virus so that symptoms of shingles do not develop. It should not be used for treating active shingles, nerve pain caused by shingles, or for the prevention of chickenpox. Vaccines may not fully protect everyone who receives them. This vaccine should not be used by children. In 2024, this provider wrote 40 Medicare prescriptions for Shingrix, about the same volume as the typical Oregon prescriber of this medication (39.9). Medicare paid an average of $211.22 per fill, versus $200.10 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40 30-Day Fills standardized to 30-day supplies 40 Days of Medication total across all patients in 2024 | |||
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 34 | $305.80 | ≈ Typical |
About Abrysvo: This vaccine is used to prevent infection by the respiratory syncytial virus (RSV). Show more ▾ Some brands may also be given during the third trimester of pregnancy to help prevent RSV in the newborn baby. RSV can cause serious illness, especially in older adults with certain health problems (such as heart disease, lung disease) and infants. It works by causing the body to produce its own protection (antibodies) against the virus. Vaccines may not fully protect everyone who receives them. In 2024, this provider wrote 34 Medicare prescriptions for Abrysvo, about the same volume as the typical Oregon prescriber of this medication (32.8). Medicare paid an average of $305.80 per fill, versus $294.83 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 34 Days of Medication total across all patients in 2024 | |||
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 28 | $63.16 | ≈ Typical |
About Boostrix Tdap: This vaccine is used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past. Show more ▾ It may also be given during the third trimester of pregnancy to help prevent pertussis in the newborn baby. Vaccination is the best way to protect against these life-threatening diseases. Vaccines work by causing the body to produce its own protection (antibodies). Booster doses are needed to keep up immunity because antibody levels may become too low over time to provide the needed protection. In 2024, this provider wrote 28 Medicare prescriptions for Boostrix Tdap, about the same volume as the typical Oregon prescriber of this medication (26.7). Medicare paid an average of $63.16 per fill, versus $62.53 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 28 Days of Medication total across all patients in 2024 | |||
| IpolPoliomyelitis Vaccine, Killed | 13 | $60.50 | ▼ Less than typical |
About Ipol: This vaccine is used to prevent a certain virus infection (polio). Show more ▾ Polio is a virus that affects mainly young children. It is usually spread by person-to-person contact. It can also be spread by eating/drinking contaminated food or water. Most people who get infected with polio have mild or no symptoms. However, some infections can be very serious and can cause inability to move (paralysis) in part of the body, such as the arms, legs, or breathing muscles. There is no cure for polio infection, but it can be prevented by vaccination. This vaccine works by increasing the body's natural defense (immunity) against the polio virus. Polio vaccine is usually given to infants and children as part of routine immunization. It may also be given to adults who haven't been immunized or who may be at increased risk for polio infection, for example by travel to countries where polio is common. Vaccines may not fully protect everyone who receives them. In 2024, this provider wrote 13 Medicare prescriptions for Ipol, about 17% of the volume of the typical Oregon prescriber of this medication (76.6). Medicare paid an average of $60.50 per fill, versus $57.69 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 13 Days of Medication total across all patients in 2024 | |||
| TwinrixHepatitis A And B Vaccine/Pf | 13 | $141.20 | ▼ Less than typical |
About Twinrix: This combination vaccine is used to help prevent infection from the hepatitis A and B viruses. Show more ▾ Hepatitis A infection can be mild with no symptoms or a severe illness that can rarely cause liver failure and death. Hepatitis B infection can cause serious problems including liver failure, long-term hepatitis B infection, cirrhosis, and liver cancer. Preventing infection with these viruses can prevent these problems. Hepatitis A/hepatitis B combination vaccine is made from whole, killed hepatitis A virus and a genetically engineered (man-made in the lab) piece of hepatitis B virus. It does not contain live virus, so you can not get hepatitis from the vaccine. This vaccine works by helping the body produce immunity (through antibody production) that will prevent you from getting infection from hepatitis A and hepatitis B. This combination vaccine does not protect you from other virus infections (such as HIV virus which causes AIDS, hepatitis C/ hepatitis E, HPV virus which causes genital warts and other problems). The vaccine is recommended for people at an increased risk of getting these infections. Those at an increased risk include health care personnel, lab workers who handle blood and patient specimens, police, fire and emergency medical personnel who give first aid treatment, hemophiliacs, dialysis patients, people who live with or spend much time with people with long-term hepatitis B or active hepatitis A infections, people with multiple sex partners, men who have sex with men, sex workers, injection drug abusers, and people traveling to high-risk areas. A combination of hepatitis A and hepatitis B vaccines. In 2024, this provider wrote 13 Medicare prescriptions for Twinrix, about 15% of the volume of the typical Oregon prescriber of this medication (88.8). Medicare paid an average of $141.20 per fill, versus $128.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 13 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MR. MATTHEW AARON BRAZER RPH is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist prescribing approach at this Eugene, OR practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OR prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
